HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Balon, H. R. Articles by Stoffer, S. S. Search for Related Content PubMed PubMed Citation Articles by Balon, H. R. Articles by Stoffer, S. S.

Technetium-99m-Sestamibi Uptake by Recurrent Hurthie Cell Carcinoma of the Thyroid

Nuclear Medicine Department, William Beaumont Hospital, Royal Oak, Michigan
Oakland Internists Associates, Southfield, Michigan

Correspondence: For reprints contact: Helena Balon, MD, Department of Nuclear Medicine, William Beaumont Hospital, 3601 W. 13 Mile Rd., Royal Oak, MI 48073-6769.

ABSTRACT

Technetium-99m-sestamibi has been reported to localize in various tumors. Scintigraphic results for a patient with recurrent Hurthle cell carcinoma of the thyroid whose tumor was imaged with both ^99mTc-sestamibi and ²⁰¹Tl, but not with ¹³¹I, are presented.

This article has been cited by other articles:

				A. Kirton, R. Kloiber, J. Rigel, and J. Wolff Evaluation of Pediatric CNS Malignancies with 99mTc-Methoxyisobutylisonitrile SPECT J. Nucl. Med., November 1, 2002; 43(11): 1438 - 1443. [Abstract] [Full Text] [PDF]

				L. Pinkas, D. Robinson, N. Halperin, L. Mindlin, M. Cohenpour, M. Baumer, and T. Horne 99mTc-MIBI Scintigraphy in Musculoskeletal Tumors J. Nucl. Med., January 1, 2001; 42(1): 33 - 37. [Abstract] [Full Text] [PDF]